Dendritic Cell Vaccination for Glioblastoma Multiforme: Clinical Experience and Future Directions

被引：0

作者：

Dejaegher, Joost ^{[1
,2
]}

Solie, Lien ^{[3
]}

De Vleeschouwer, Steven ^{[1
,2
]}

Van Gool, Stefaan W. ^{[2
,3
]}

机构：

[1] Katholieke Univ Leuven, Dept Neurosci, Lab Expt Neurosurg & Neuroanat, Leuven, Belgium

[2] Univ Hosp Leuven, Leuven, Belgium

[3] Katholieke Univ Leuven, Dept Microbiol & Immunol, Pediat Oncol, Leuven, Belgium

来源：

2014 6TH INTERNATIONAL ADVANCED RESEARCH WORKSHOP ON IN SILICO ONCOLOGY AND CANCER INVESTIGATION (IARWISOCI) | 2014年

关键词：

REGULATORY T-CELLS; RECURRENT MALIGNANT GLIOMA; TUMOR VACCINATION; EXOGENOUS ANTIGEN; IMMUNE DEFECTS; IMMUNOTHERAPY; RESPONSES; COMBINATION; GENERATION; CHILDREN;

D O I：

暂无

中图分类号：

TM [电工技术]; TN [电子技术、通信技术];

学科分类号：

0808 ; 0809 ;

摘要：

Dendritic cell vaccination is an experimental treatment for malignant gliomas, and has been subject of a translational program for more than ten years in our center. In vitro research, animal models and clinical trials for relapsed and newly diagnosed patients have been conducted. In this paper, we give an overview of the mechanism and rationale of this treatment for brain cancer. We also briefly discuss recently updated results of our clinical trials. Finally, we mention strategies to select patients for this therapy and additional immunotherapeutic strategies to further enhance the antitumor immune responses.

引用

页数：5

共 50 条

[31] New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme
Wilkinson, Jonathan
[J]. IMMUNOTHERAPY, 2014, 6 (03) : 229 - 229
[32] Dendritic cell vaccination in glioblastoma after fluorescence-guided resection
Diez Valle, Ricardo
Lopez-Diaz de Cerio, Ascension
Inoges, Susana
Tejada, Sonia
Pastor, Fernando
Villanueva, Helena
Gallego, Jaime
Espinos, Jaime
Aristu, Javier
Angel Idoate, Miguel
Andreu, Enrique
Bendandi, Maurizio
[J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2012, 3 (11): : 142 - 149
[33] Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
Batich, Kristen A.
Swartz, Adam M.
Sampson, John H.
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (01) : 79 - 94
[34] New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme
Wilkinson, Jonathan
[J]. FUTURE NEUROLOGY, 2014, 9 (02) : 115 - 115
[35] New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme
Wilkinson, Jonathan
[J]. FUTURE ONCOLOGY, 2014, 10 (04) : 504 - 504
[36] Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
De Vleeschouwer, Steven
Fieuws, Steffen
Rutkowski, Stefan
Van Calenbergh, Frank
Van Loon, Johannes
Goffin, Jan
Sciot, Raf
Wilms, Guido
Demaerel, Philippe
Warmuth-Metz, Monika
Soerensen, Niels
Wolff, Johannes E. A.
Wagner, Sabine
Kaempgen, Eckhart
Van Gool, Stefaan W.
[J]. CLINICAL CANCER RESEARCH, 2008, 14 (10) : 3098 - 3104
[37] HPV vaccination: Clinical potential, implementation challenges, and future directions
Perkins, Rebecca B.
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (06) : 1327 - 1331
[38] Hemiparesis following influenza vaccination - Glioblastoma multiforme.
Selvaraj, N
Moonis, M
Ravin, P
[J]. POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (876) : 633 - 635
[39] Epidermal Growth Factor Receptor Vaccination for Glioblastoma Multiforme
Komotar, Ricardo J.
Starke, Robert M.
Connolly, E. Sander
Sisti, Michael B.
[J]. NEUROSURGERY, 2011, 68 (02) : N22 - N23
[40] Surgical outcomes of glioblastoma multiforme in low and middle-income countries: current state and future directions
Abdulbasit Opeyemi, Muili
Aderinto, Nicholas
Akinmeji, Ayodeji
Mustapha, Fatihi Bamigbola
Mubarak, Jolayemi Mustapha
Joshua, Ayodele Yusuf
Kuol, Piel Panther
Rebecca Opeyemi, Adeyemo
Alare, Kehinde
Olatunji, Gbolahan
Emmanuel, Kokori
[J]. ANNALS OF MEDICINE AND SURGERY, 2024, 86 (09): : 5326 - 5333

← 1 2 3 4 5 →